Pharmaceutical drugs like RAS inhibitors, sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) are mainly used in treating DKD. The gene discussed is SLC5A2; the disease is diabetic kidney disease.